Stefan Sperl
14Patents
6h-index
21Co-inventors
66Inventor score
Filing activity: Aug 23, 2000 → Mar 23, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7608623B2 | Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors | Chemistry; Metallurgy | 15 | Expired |
| US6841702B2 | Highly selective inhibitors of the urokinase plasminogen activator | Chemistry; Metallurgy | 14 | Expired |
| US7208521B2 | Selective inhibitors of the urokinase plasminogen activator | Chemistry; Metallurgy | 8 | Expired |
| US7049460B1 | Selective inhibitors of the urokinase plasminogen activator | Chemistry; Metallurgy | 8 | Expired |
| US7038074B2 | Arginine mimetics as factor Xa inhibitors | Chemistry; Metallurgy | 7 | Expired |
| US7247724B2 | Method for the production of phenylalanine derivatives | Chemistry; Metallurgy | 6 | Expired |
| US7659396B2 | Method for the production of phenylalanine derivatives | Chemistry; Metallurgy | 6 | Active |
| US7807681B2 | Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors | Chemistry; Metallurgy | 6 | Active |
| US7538216B2 | Guanidino phenylalanin compounds used as urokinase inhibitors | Chemistry; Metallurgy | 6 | Expired |
| US7049344B2 | Highly selective inhibitors of the urokinase plasminogen activator | Chemistry; Metallurgy | 1 | Expired |
| US12209073B2 | Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor | Chemistry; Metallurgy | 1 | Active |
| US11730716B2 | Compounds for treating ophthalmic diseases and disorders | Human Necessities | 1 | Active |
| US12364680B2 | Compounds for treating ophthalmic diseases and disorders | Human Necessities | 0 | Active |
| US12077517B2 | Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.